Epidemiology of invasive and non-invasive pneumococcal infections in hospitalised adult patients in a Lebanese medical centre, 2006–2015

Abstract

This is a retrospective medical file review of adult inpatients with Streptococcus pneumoniae infections admitted to a Lebanese hospital between 2006 and 2015. We revisited the clinical scenarios of these infections in view of increasing antibiotic resistance in Lebanon. One hundred and three patients were included; 92% were eligible for pneumococcal vaccination, yet none were vaccinated. Non-invasive pneumococcal disease (non-IPD) represented 64% of these infections. Superinfections caused by antibiotic-resistant bacteria were documented in 17.5% of the patients, with the predominance of ventilator-associated pneumonia (12.6%). Kidney disease and septic shock were positive predictors for mortality [adjusted odds ratio (OR) = 14.96, 95% confidence interval (CI) 2.34–95.45, P = 0.004; OR = 5.09, 95% CI 1.33–19.51, P = 0.02, respectively]. Herein, the differences in clinical success, S. pneumoniae infection-related death, and total mortality were not statistically significant between invasive pneumococcal disease (IPD) and non-IPD subgroups (59.5% vs. 77.3%, P = 0.056; 21.6% vs. 9.1%, P = 0.08; and 35.1% vs. 22.7%, P = 0.174; respectively). Upon comparing antibiotic susceptibility of S. pneumoniae during the first two years of the study (2006–2007) (n = 32 isolates) and the last two (2014–2015) (n = 14 isolates), there was an increasing non-susceptibility to penicillin (34.4%–50.0%, P = 0.25), and a decreasing susceptibility to erythromycin and clindamycin (81.3%–78.6%, P = 0.67 and 90.6%–85.7%, P = 0.65; respectively). © 2020

Description

Keywords

Invasive pneumococcal disease, Lebanon, Non-invasive pneumococcal disease, Serotype, Streptococcus pneumoniae, Adult, Anti-bacterial agents, Hospitals, Humans, Infant, Pneumococcal infections, Pneumococcal vaccines, Retrospective studies, Serotyping, Ampicillin, Beta lactam antibiotic, Carbapenem derivative, Ceftriaxone, Cephalosporin derivative, Clindamycin, Erythromycin, Levofloxacin, Macrolide, Meropenem, Oxacillin, Penicillin derivative, Penicillin v, Piperacillin plus tazobactam, Pneumococcus vaccine, Quinoline derived antiinfective agent, Vancomycin, Antiinfective agent, Acinetobacter baumannii, Acinetobacter infection, Advisory committee, Aged, Antibiotic resistance, Antibiotic sensitivity, Antibiotic therapy, Antimicrobial stewardship, Article, Bacterium culture, Bacterium isolate, Case fatality rate, Clinical outcome, Combination drug therapy, Community acquired pneumonia, Controlled study, Disease course, Erythromycin resistance, Female, Follow up, Hospital acquired pneumonia, Hospital admission, Hospital patient, Human, In vitro study, Intensive care unit, Kidney disease, Lebanese, Major clinical study, Male, Medical record review, Minimum inhibitory concentration, Monotherapy, Mortality, Multiplex polymerase chain reaction, Pneumococcal infection, Pneumococcal meningitis, Priority journal, Pseudomonas infection, Retrospective study, Septic shock, Stenotrophomonas maltophilia, Superinfection, Tertiary care center, Vaccination, Ventilator associated pneumonia, Hospital

Citation

Endorsement

Review

Supplemented By

Referenced By